EHC vs THC
Encompass Health Corporation and Tenet Healthcare Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | EHC | THC |
|---|---|---|
| Revenue | $5.9B | $21.3B |
| Net income | $566.2M | $2.4B |
| Gross margin | — | — |
| Net margin | 9.5% | 11.1% |
| Return on equity | 25.1% | 56.4% |
| Diluted EPS | $5.54 | $15.49 |
| Dividend / share | $0.72 | — |
| Payout ratio | 12.6% | — |
| Free cash flow | $439.2M | $2.5B |
| Equity | $2.4B | $4.2B |
| Net debt / equity | 0.97× | 2.42× |
| Current ratio | 1.08× | 1.76× |
| Revenue CAGR 5y | 10.7% | 3.9% |
| Profit CAGR 5y | 14.8% | 25.2% |
THC bills 3.6× the revenue of EHC, and keeps more of each dollar of revenue as profit (11.1% against 9.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | EHC | THC |
|---|---|---|
| FY2025 | $5.9B | $21.3B |
| FY2024 | $5.4B | $20.7B |
| FY2023 | $4.8B | $20.6B |
| FY2022 | $4.3B | $19.2B |
| FY2021 | $4.0B | $19.5B |
| FY2020 | $3.6B | $17.6B |
| FY2019 | $4.6B | $18.5B |
| FY2018 | $4.3B | $18.3B |
| FY2017 | $3.9B | $20.6B |
| FY2016 | $3.6B | $21.1B |
Net income by year
Bottom line
| Fiscal year | EHC | THC |
|---|---|---|
| FY2025 | $566.2M | $2.4B |
| FY2024 | $455.7M | $4.1B |
| FY2023 | $352.0M | $1.3B |
| FY2022 | $271.0M | $1.0B |
| FY2021 | $412.2M | $1.5B |
| FY2020 | $284.2M | $768.0M |
| FY2019 | $358.7M | $171.0M |
| FY2018 | $292.3M | $459.0M |
| FY2017 | $271.1M | $-320.0M |
| FY2016 | $247.6M | $176.0M |
Advertisement
AdSense · Rectangle 336×280